Related Experiment Videos
Improving treatment for persons with schizophrenia
1University of Maryland, Center for Mental Health Services Research, Baltimore 21201, USA. alehman@umpsy.umaryland.edu
The Psychiatric Quarterly
|December 10, 1999
Summary
Developing standards for schizophrenia treatment is crucial for quality, cost-effective care. Evidence-based practices must be widely implemented to improve patient outcomes and ensure ongoing quality improvement in mental health services.
Area of Science:
- Psychiatry and Mental Health Services Research
- Health Services Management and Policy
Background:
- Growing need for standardized, high-quality, and cost-effective schizophrenia treatment.
- Advances in neuroscience and treatment efficacy underscore the necessity for updated care standards.
- Increased patient advocacy and healthcare cost pressures necessitate a focus on evidence-based practices.
Purpose of the Study:
- To advocate for the development of standards for schizophrenia treatment.
- To address the gap between evidence-based practices and current patient care.
- To promote quality improvement and cost-effectiveness in mental health services.
Main Methods:
- Review of substantial evidence on pharmacotherapies, psychological, family, and vocational interventions.
- Analysis of current service system delivery for schizophrenia care.
- Emphasis on resource allocation considering both effectiveness and cost.
Main Results:
- Significant evidence supports various treatments for schizophrenia, including pharmacotherapy and psychosocial interventions.
- Many patients are not receiving treatments aligned with current evidence.
- Existing service systems require enhancement to ensure access to efficacious treatments.
Conclusions:
- Service systems must prioritize the availability of evidence-based treatments for schizophrenia.
- Resource allocation should balance treatment effectiveness with cost-efficiency.
- Implementing robust evaluative systems is essential for continuous quality improvement in schizophrenia care.